EPI-CENTER.AI: MORE THAN HALF A MILLION EUROS IN FUNDING FROM THE FEDERAL MINISTRY OF RESEARCH, TECHNOLOGY AND SPACE

Epilepsy is one of the most common neurological disorders, but one third of cases are drug-resistant. In these cases, epilepsy surgery may be an option, however, many people affected cannot be helped because epilepsy surgery is not considered an option or the epileptogenic lesion cannot be found.

epi-center.ai navigates the patient journey of people affected by epilepsy, coordinates online networking with epilepsy centers, and uses artificial intelligence to help healthcare providers find the epileptogenic lesion. Together, healthcare providers and epi-center.ai can find more epileptogenic lesion and more accurately predict the clinical success of epilepsy surgery. The interpersonal relationship between patients and healthcare providers is complemented, not replaced, by epi-center.ai. Patients and healthcare providers are connected with each other and with the technology in a hybrid manner. The interaction of patients with epi-center.ai has a screening function for all people who are potentially eligible for epilepsy surgery.

Thanks to epi-center.ai, people affected by epilepsy can be supported at every stage of their patient journey through a variety of digital applications. epi-center.ai can thus become an app-based or web-based companion for epilepsy patients and healthcare professionals.

Theodor Rüber and the Translational Neuroimaging Team receives around €518,000 to conduct the pre-market research leading to the spin-off of the company.

© Volker Lannert/Uni Bonn